Transfusion-associated graft-versus-host disease: an update

By Dal-Pont Christian   Schennach Harald  

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 254-257

Springer Publishing Company

Access to resources Recommend Favorite

Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma

By El-Rayess Hebah M.  

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1213-1214

Informa Healthcare

Access to resources Recommend Favorite

Targeting CD83 for the treatment of graft-versus-host disease (Review)

By Wang Xiongfei   Wei Ming Q.   Liu Xiaosong  

Experimental and Therapeutic Medicine, Vol. 5, Iss. 6, 2013-06 ,pp. : 1545-1550

Spandidos Publications

Access to resources Recommend Favorite

National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine–busulfan–antithymocyte globulin conditioning regimen

By Saillard Colombe   Crocchiolo Roberto   Furst Sabine   El-Cheikh Jean   Castagna Luca   Signori Alessio   Oudin Claire   Faucher Catherine   Lemarie Claude   Chabannon Christian   Granata Angela   Blaise Didier  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1106-1112

Informa Healthcare

Access to resources Recommend Favorite

Suppression of graft-versus-host disease and retention of graft-versus-tumour reaction by murine genetically engineered dendritic cells following bone marrow transplantation

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3820-3827

Spandidos Publications

Access to resources Recommend Favorite